GlassScriptPrepare for your visit
Michael Robinson
Infectious Disease · Greenville, NC · NPI 1881670016
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,102.48
in general payments reported to CMS, 2019-2025 · $195 in 2025
The $195 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Who reported paying
General payments only, top 6 by amount.
- Viiv Healthcare Company $2,221.61
- Gilead Sciences, INC. $900.72
- Amgen INC. $139.08
- Paratek Pharmaceuticals, INC. $125.00
- Tesaro, INC. $125.00
- Janssen Products, LP $99.00
Drugs and devices associated with these payments
Dovato Epclusa Biktarvy Cabenuva Yeztugo Aptima Thinprep 2000 Processor Rezzayo Delstrigo Vowst Symtuza
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/39529/michael-robinson